Is Avenue Therapeutics, Inc. (ATXI) a Buy, Sell, or Hold?
OTC : ATXI
Avenue Therapeutics, Inc.
$0.2551 USD
$0 (0.0%)
- Volume
- 10
- Average Volume
- 3.24K
- Market Capitalization
- $840.55K
- P/E Ratio
- -0.30
- Dividend Yield
- 0.00%
- Price Target
- $12.00
- Year High
- $0.97
- Year Low
- $0.15
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.38
Company Overview
OTC
Alexandra MacLean
Biotechnology
Healthcare
ATXI
1
US
USD
Liquidity Metrics
0.00
1.38
1.38
1.38
0.00
Sales & Valuation
$1.4M
0.00
1.48
-0.61
-0.42
Profitability
-$0.93
-$2.91M
0.00%
0.00%
-155.23%
-140.54%
P/E Metrics
-0.30
0.00
0.00
Analyst Price Target & Rating
$12.00
$12.00
$12.00
2/5
1 Analysts
-97.87%
Financial Health Scores
-80.12
1/9
$535K
$1.98M
$1.41M
-$3.06M
Key Metrics (TTM)
-$1.1M
0.00
0.36
1.38
-155.23%
-579.44%
-330.38%
-164.65%
0 days
Company Executives
| Name | Title |
|---|---|
| Alexandra MacLean | Chief Executive Officer & Director |
| Lindsay Allan Rosenwald | Executive Director |
| David Jin | Interim Chief Financial Officer, Chief Operating Officer & Corporate Secretary |
Poll Results
No votes yet today — be the first to share your view!
About Avenue Therapeutics, Inc. (OTC:ATXI) Stock
Avenue Therapeutics, Inc. functions as a specialized pharmaceutical enterprise, primarily dedicated to innovating and bringing to market medical therapies tailored for critical and intensive care environments within hospitals. Their leading product candidate is intravenous Tramadol, a synthetic opioid with a dual mechanism of action, currently undergoing Phase III clinical trials for the management of severe pain experienced by patients after surgery. Established in 2015, the company's operations are based in New York, New York. ...
Frequently Asked Questions
-
What is the current Avenue Therapeutics, Inc. (ATXI) stock price?
-
Avenue Therapeutics, Inc.(OTC:ATXI) stock price is $0.2551 in the last trading session. During the trading session, ATXI stock reached the peak price of $0.9699 while $0.15 was the lowest point it dropped to. The percentage change in ATXI stock occurred in the recent session was 0.0% while the dollar amount for the price change in ATXI stock was $0.
-
ATXI's industry and sector of operation?
-
The OTC listed ATXI is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of ATXI?
-
Alexandra MacLean | Chief Executive Officer & Director
Lindsay Allan Rosenwald | Executive Director
David Jin | Interim Chief Financial Officer, Chief Operating Officer & Corporate Secretary
|
| -
How many employees does ATXI have?
-
Number of ATXI employees currently stands at 1. ATXI operates from 1111 Kane Concourse, Bay Harbor Islands, FL 33154, US.
-
Link for ATXI official website?
-
Official Website of ATXI is: https://www.avenuetx.com
-
How do I contact ATXI?
-
ATXI could be contacted at phone #781 652 4500 and can also be accessed through its website. ATXI operates from 1111 Kane Concourse, Bay Harbor Islands, FL 33154, US.
-
How many shares of ATXI are traded daily?
-
The average number of ATXI shares traded daily for last 3 months was 3.24K.
-
What is the market cap of ATXI currently?
-
The market value of ATXI currently stands at $840.55K with its latest stock price at $0.2551